title: Lack of enterohepatic circulation of the active metabolite of nabumetone in humans.
authors: Clinical Pharmacology Research Institute, SmithKline Beecham Pharma, Neuss, Germany.
authors: M A
authors: MA
authors: Brett
authors: G
authors: G
authors: Buscher
authors: E
authors: E
authors: Ellrich
authors: W H
authors: WH
authors: Greb
authors: H J
authors: HJ
authors: Kurth
authors: G
authors: G
authors: Rülander
authors: B
authors: B
authors: Schmerenbeck
authors: R
authors: R
authors: Haddock
authors: A
authors: A
authors: Thawley
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism; D002074:Butanones / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000494:pharmacology; D004311:Double-Blind Method; D004764:Enterohepatic Circulation; D006801:Humans; D008297:Male; D000077430:Nabumetone; D009280:Naphthaleneacetic Acids / Q000097:blood*; D009994:Osmolar Concentration; D010919:Placebos; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D009280:Naphthaleneacetic Acids; D010919:Placebos; D002792:Cholestyramine Resin; C044612:6-methoxy-2-naphthylacetic acid; D000077430:Nabumetone